https://prod.cdn.everyaction.com

Environmental Health Trust is a 501(c)(3) non-profit organization.

We depend on generous donations from our community.  

Join Our Newsletter | Healthy Tech at Home Project | Wildlife and Wireless

https://www.thefocalpoints.com/p/new-study-high-wireless-emf-exposure?

NEW STUDY: High Wireless EMF Exposure More Than Triples Risk of Neurodevelopmental Delays in Infants

First-ever infant cohort study using direct home RF-EMF measurements finds major increases in motor, problem-solving, and social deficits — even at everyday Wi-Fi and cell tower levels.

A major new study titled, Radiofrequency Electromagnetic Field Emissions and Neurodevelopmental Outcomes in Infants: A Prospective Cohort Studyhas delivered one of the clearest warnings yet about the effects of everyday wireless radiation on babies.

Unlike past research based on phone-use surveys, this team directly measured radiofrequency electromagnetic fields (RF-EMF) inside homes — from sources like cell towers, Wi-Fi routers, cordless phones, and Bluetooth devices — and tracked real brain and motor development in infants over their first year.

The result? Higher in-home radiation was strongly linked to delays in fine motor skills, problem-solving ability, and social development — even after accounting for birth weight, maternal age, and income level.

What They Measured

Scientists went into homes with a professional spectrum analyzer, measuring total RF-EMF from all sources in the living environment — not just cell towers.

This included:

  • Wi-Fi routers (often running 24/7)

  • Cordless phones and their base stations

  • Bluetooth devices like speakers, earbuds, and baby monitors

  • Nearby cell towers

  • Smart TVs, tablets, and smart home hubs

(See link for article & video)

_______________

**Comment**

The study showed that everyday wireless radiation in the home at levels most would consider ‘normal’ may harm brain development with babies as they faced nearly 2-4 times the odds of developmental delays.

For more:

https://danielcameronmd.com/lymeseek-lyme-blood-test/

New Lyme Blood Test Outperforms Standard Testing

Lyme Science Blog

Aug26

New Lyme Blood Test LymeSeek Promises Earlier, More Accurate Diagnosis

Lyme disease is one of the few infections where patients are often diagnosed too late — not because they waited, but because testing could not detect the infection until later stages – if at all.

A new Lyme blood test called LymeSeek could change that. It aims to revolutionize Lyme diagnostics by delivering significantly higher accuracy, especially in early disease detection — where current tests often fall short.

Holly Ahern, MS, MT, Chief Scientific Officer at Aces Diagnostics, discusses LymeSeek. For more information, visit https://www.acesdiagnostics.com/lymeseek

According to data presented at the 2025 Association for Diagnostics and Laboratory Medicine meeting, LymeSeek demonstrated over 90% sensitivity and specificity in detecting Lyme disease across all phases of illness — from early localized to post-treatment.

That’s a significant improvement over standard two-tier testing, which often misses early cases when treatment matters most. Reliable testing is particularly important since an estimated 30% of patients never develop the classic bull’s-eye rash, which most practitioners rely on for diagnosing the disease.


Why Current Lyme Testing Often Fails

Current Lyme disease tests miss many infections — especially early ones — mainly because of how they work and what they’re looking for.

They don’t detect the bacteria itself

  • Most current tests (like the CDC-recommended two-tier testing) look for antibodies your immune system makes against Borrelia burgdorferi. However, it can take several days to weeks for antibodies to develop. That means serologic testing can produce false negatives — especially in the first 2–4 weeks after infection. This is one of the biggest frustrations for providers treating patients in Lyme endemic areas. Many patients never test positive

The CDC’s recommended two-tier system is rigid and outdated

  • Patients are initially given an ELISA test. If positive or equivocal, they then receive the Western blot. If either of these test results are negative, the patient supposedly doesn’t have Lyme disease – even when they might.

  • This system was designed decades ago mainly for surveillance, not for highly sensitive early diagnosis.

Borrelia’s biology makes testing tricky

  • The bacteria changes the proteins it expresses at different stages of infection, meaning antibody targets aren’t consistent.

  • It can hide in tissues and reduce exposure to the immune system (immune evasion), which delays or blunts antibody production.

Strain and species variation

  • U.S. tests focus mainly on B. burgdorferi sensu stricto. If someone is infected with another species like: B. mayoniiB. garinii, or B. afzelii, testing may not detect those antigens, leading to a false negative result.

Past infection vs. active infection confusion

  • Once antibodies form, they can persist for months to years after treatment. Therefore, testing cannot distinguish whether an infection is newongoing, or old. A patient may have an old infection that has resolved and doesn’t require treatment.

What Makes This New Lyme Blood Test Different?

The new Lyme blood test uses a multiplexed antigen assay—testing for 10 different immune responses at once. Then, a machine learning algorithm interprets the results. This approach improves both sensitivity and specificity, especially in early disease when antibodies are still forming.

In head-to-head comparison:

  1. In early disease (0–72 hours after EM rash), LymeSeek detected 100% of cases vs. just 37% with standard testing.

  2. In post-treatment Lyme (6+ months after infection), LymeSeek identified 97% of cases vs. 46% with standard tests.

That means better detection without waiting for seroconversion, and better confirmation of past infection when patients present with persistent symptoms.


Will This Test Change Lyme Disease Care?

It could—eventually.

This new Lyme blood test may help:

  1. Identify early Lyme before antibodies form

  2. Confirm cases when no rash is present

  3. Support diagnosis in patients with ongoing symptoms after treatment


Is the New Lyme Blood Test Available Now?

🚫 It is not yet FDA-approved or available for patient ordering through clinics or commercial labs.

ACES Diagnostics is currently working with the FDA on clinical trial pathways. The test has received a De Novo classification, meaning it’s being evaluated as a novel diagnostic tool—not just compared to current testing.

If approved, LymeSeek could be a game-changer for early Lyme detection and for patients with post-treatment symptoms who need better answers.


Final Thoughts

A new test can’t fix every challenge that comes with Lyme disease. But it could mean getting answers sooner, missing fewer cases, and giving doctors more confidence in diagnosing.


Links

  1. Clinical Testing and Diagnosis for Lyme Disease

  2. LymeSeek: Blood test with 90% accuracy

  3. Why I Treat Babesia Even if the Tests Are Negative

https://popularrationalism.substack.com/p/bulletin-fourteenyear-fugitive-from?

BULLETIN: Fourteen‑Year Fugitive from Justice Poul Thorsen Arrested in Germany for Defrauding the US Government: What This Means for the Vaccine/Autism Question

Resources. As always, we present the facts without speculation. Background and facts you can use.

Poul Thorsen, a Danish physician and researcher prominently involved in vaccine‑autism epidemiology, was indicted in 2011 in the U.S. for allegedly misappropriating more than $1 million in CDC grant funds. For over a decade he was a fugitive who face, name and charges were openly displayed on the US OIG Most wantedBreitbart News has reported Thorsen was arrested in June under INTERPOL red notice.

This POPULAR RATIONALISM BULLETIN article reconstructs Thorsen’s academic contributions, the criticisms of his methodological work, the legal findings, and the implications for public policy and scientific trust. It places legal culpability in the context of scientific reliability/implications for other Danish studies, identifies where those studies he co‑authored have been called out for design weaknesses or uncorrected biases, and outlines what must be done to restore clarity.  (See link for timeline and article)

For More:

The following study never underwent peer review and was never published, because the authors — staunch vaccine supporters — told ICAN attorney Aaron Siri they were concerned about losing their jobs or reputations because their findings contradicted the official public health narrative and vaccine policy.  Lois Lamerato, Ph.D., who had worked on the study told Siri she and her coauthor both thought the study was well done and worthy of publication.  But the “higher-ups” at Henry Ford Health, to whom she was required to send a copy before submission, did not want to submit it. Lamerato also said she was worried the study, if published, would make doctors feel uncomfortable.

Go here for a 2 min video summing it all up.

https://www.thefocalpoints.com/p/breaking-henry-ford-vaxxed-vs-unvaxxed?

BREAKING: Henry Ford Vaxxed vs. Unvaxxed Study Found Vaccinated Kids Had 453% More Neurodevelopmental Disorders — 57% Rendered Chronically Ill

The largest vaccinated vs. unvaccinated birth cohort study in U.S. history (n=18,468) tracked children for 10 years — and revealed staggering increases in chronic disease among the vaccinated.

Today, attorney Aaron Siri testified before the U.S. Senate’s Permanent Subcommittee on Investigations during the hearing titled:

“How the Corruption of Science has Impacted Public Perception and Policies Regarding Vaccines.”

In his sworn testimony, Siri revealed the results of a long-hidden study from the Henry Ford Health System in Detroit, MI.

This is the largest vaccinated vs. unvaccinated birth cohort study ever conducted in the United States (n=18,468). Children were tracked from birth over a 10-year period. The data were drawn directly from electronic medical records — the gold standard for real-world health outcomes.

The study’s official title: “Impact of Childhood Vaccination on Short- and Long-Term Chronic Health Outcomes in Children: A Birth Cohort Study.”

The measures and outcomes cited below come directly from the testimony of Aaron Siri, who presented these findings under oath in the U.S. Senate. Unfortunately, the study is not yet publicly available. (See link for video and key findings)

______________

KEY FINDINGS

Compared to unvaccinated children, those who received one or more vaccines had dramatically higher rates of chronic illness:

  • 329% more asthma
  • 203% more atopic disease
  • 496% more autoimmune disease
  • 453% more neurodevelopmental disorders
    • including 228% more developmental delays
    • and 347% more speech disorders
Siri testified that all of these findings were statistically significant.

Informed Consent Action Network (ICAN) and Del Bigtree have dedicated an entire documentary film to it, aptly titled An Inconvenient Study,” to be released October 3, 2025.

On X, President Trump posted an old video of renowned geneticist and the Director of genetics at Maryland Medical Library, Dr. Mark Geier, about how POISONOUS Thimerosal in vaccines is.

The video captions:

“They’re ALL poison. Every. Single. One.”

This comes JUST before RDK Jr is set to release his autism report, and the newly dropped evidence that proves Fauci ordered staff to delete emails after reading them.
Finally, the FDA is conducting an ‘Intense Investigation’ of Child deaths following the COVID clot shot.

http://  Approx. 12 Min

Vaccinated People At Risk For Chronic Illness

Sept. 8, 2025

The Economic Times

For more:

https://childrenshealthdefense.org/defender/aap-hasnt-updated-advice-cellphone-radiation-nearly-decade-att-listed-among-funders/

AAP Hasn’t Updated Advice on Cellphone Radiation in Nearly a Decade — AT&T Listed Among Funders

The American Academy of Pediatrics hasn’t updated its parental guidance on cellphone radiation in nearly a decade, despite numerous studies in recent years highlighting the dangers of exposure in children. A link on the group’s parenting advice webpage lists telecommunications company AT&T as one of its corporate sponsors.

parent and child and AT&T logo

The American Academy of Pediatrics (AAP) hasn’t updated its parental guidance on cellphone radiation since 2016, even though studies published in recent years highlight the dangers of exposure in children.

A link on the group’s wireless radiation webpage lists telecommunications company AT&T as one of its corporate sponsors.

The AAP, which represents 67,000 pediatricians in the U.S., says its mission is to “attain optimal physical, mental, and social health and well-being for all infants, children, adolescents and young adults.”

The group runs a parenting advice website — HealthyChildren.org — which includes a page on cellphone radiation. Five corporations sponsor the site, including AT&T, Vicks and pharmaceutical companies Regeneron, Sanofi and Genentech.

“It appears the website’s financial support may be influencing its content,” said Miriam Eckenfels, director of Children’s Health Defense’s (CHD) Electromagnetic Radiation & Wireless Program.

The AAP’s parenting website advertises a “free” webinar for parents on how immunizations for RSV, or respiratory syncytial virus, can keep their babies “safe.” Sanofi, which sells an RSV shot, is sponsoring the event.

“Meanwhile, the AAP hasn’t bothered updating its cellphone radiation advice to parents in over nine years — despite the rapid proliferation of cellphones and other ‘smart’ devices in kids’ environments,” Eckenfels said.

She added:

“Examples of industry supporting the AAP are common, and we are wary of any attempt to capture not just government agencies but also professional organizations.

“We need to ensure, through education and advocacy, that the financial incentives don’t impact their recommendations — and push back as soon as they do.”

AAP’s cellphone radiation page says ‘latest research’ is from 2016

The AAP’s “Cell Phone Radiation & Children’s Health: What Parents Need to Know” page was last updated on June 13, 2016.

The page reports on what it calls the “latest research” by citing partial findings from the 2016 National Toxicology Program’s (NTP) two-year study on cellphone radiation, which showed that rats exposed to cellphone radiation had an increased risk of cancer.

The webpage says “parents should not panic” and notes that the study focused on rats, not people. “We do not yet know if the same results would occur in people,” according to the webpage. “The analysis of all of the data from this study is not yet complete,” the webpage states.

The NTP published the study’s full findings in 2018.

“Why did the AAP not update its webpage in 2018, once the NTP completed the study and found ‘clear evidence’ of increased cancer risk?” Eckenfels asked.

Numerous other studies published since 2016 underscore the health risks of cellphone radiation.

In 2018, Italy’s Ramazzini Institute also found evidence of cancer in rats exposed to cellphone radiation.

Earlier this year, a systematic review commissioned by the World Health Organization concluded there is “high certainty” evidence that cellphone radiation exposure causes two types of cancer in animals.

The AAP’s cellphone radiation webpage calls for more research, despite failing to update its content with current studies.

It also includes “safety tips” for parents to help their children avoid “unnecessary radiation exposure,” such as limiting children’s cellphone use and downloading movies to watch with the device set to airplane mode.

“But note that AAP isn’t offering a free parent webinar to get these tips out to the public,” Eckenfels said. “Instead, they are buried on a neglected webpage.”

The AAP did not respond when asked why it hasn’t updated its cellphone radiation webpage for parents. Neither the AAP nor AT&T responded when asked how much money AT&T has contributed to the parenting website and for how long.

AAP supports ‘review of radiation standards,’ but will it take action?

The webpage points out that the Federal Communications Commission (FCC), which sets the regulatory limit for cellphone radiation, hasn’t reviewed its standards since 1996.

The page also acknowledges that it’s a “problem” that the FCC’s cellphone radiation test assumes the cellphone user is an adult, not a child. “Children’s skulls are thinner and can absorb more radiation,” the page states.

The AAP appears committed to advocating for the FCC to review its limits, stating:

“The AAP supports the review of radiation standards for cell phones in an effort to protect children’s health, reflect current cell phone use patterns, and provide meaningful consumer disclosure.”

In 2021, CHD earned a “historic win” against the FCC, challenging the agency’s decision not to review its 1996 health and safety guidelines for wireless-based technologies.

However, the FCC has yet to comply with the court mandate to explain how its radiofrequency (RF) radiation exposure guidelines adequately protect humans from harm.

The majority opinion said the agency must also:

“(ii) address the impacts of RF radiation on children, the health implications of long-term exposure to RF radiation, the ubiquity of wireless devices, and other technological developments that have occurred since the Commission last updated its guidelines, and (iii) address the impacts of RF radiation on the environment.”

The petitioners in the case filed 11,000 pages of evidence of harm from 5G and wireless technology, including evidence of existing widespread sickness.

In April 2023, CHD petitioned the FCC to “quit stalling” and comply with the court-ordered mandate. The agency still shows no sign of complying, Eckenfels said.

The AAP did not respond when asked if it planned to petition the FCC to comply with a 2021 court mandate.

Related articles in The Defender